COVID-19
Pınar Korkmaz and others
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It spread rapidly, resulting in a pandemic throughout the world. In February 2020, the World Health Organization (WHO) named the disease COVID-19. Studies reported that COVID-19 mostly progressed with asymptomatic (...) Read More
Derya Yapar and others
The number of cases of coronavirus disease 2019 (COVID-19) continues to threaten the world by increasing day by day. COVID-19 primarily affects the respiratory system and the most common clinical symptoms are fever, cough (...) Read More
Kayıhan Pala and others
Estimations about confirmed COVID-19 deaths may be limited to the testing capacity and frequency, along with correct and complete reporting of the cause of deaths (1). The number of confirmed and probable COVID-19 deaths may not include people who (...) Read More
Oya Özlem Eren-Kutsoylu and others
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the disease called the coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020, and on the same day, the Republic of Turkey (...) Read More
Sevil Alkan-Çeviker and others
Coronavirus disease 2019 (COVID-19) was declined as a pandemic by the World Health Organization (WHO) in March 2020. The initial diagnosis of the disease was made in a very complex process. In addition to treating and preventing its spread, vaccination (...) Read More
Önder Ergönül and others
About the last 10-year if not older, electronic learning as a training method in infectious diseases (ID) and clinical microbiology (CM) was defined as an area to be improved. In a survey published in 2017 by the European Society of Clinical Microbiology (...) Read More
Murat Akova
As of August 21, 2021, more than 32% of the world population has received at least one dose of the COVID-19 vaccine and almost one fourth is fully vaccinated. However, only 1.4% of the population in the developing world have received at least one dose. While the pandemic (...) Read More
Mehmet Yıldız and others
The COVID-19 pandemic emerged in Wuhan in December 2019 and spread rapidly all over the world. The number of cases worldwide reached a total of 150 million as of May 2021. While 14% of these cases required hospitalization with severe pneumonia (...) Read More
Asiye Bahar Kaçmaz and others
The SARS-CoV-2 infection has influenced the whole world and every day, both the number of cases and deaths related to the COVID-19 pandemic continue to rise. Eighty-one percent of COVID-19 cases are mild, 14% are serious and 5% are critical. Although the overall mortality rate was 2.3%, mortality (...) Read More
Mahir Kapmaz and others
The clinical findings of SARS-CoV-2 infection are heterogeneous, and the duration of viral RNA shedding varies on the age of the patient, severity of the disease, and type of the sample. For that reason, a comprehensive analysis of the dynamics of viral shedding is critical for (...) Read More
Çiğdem Erol and others
SARS-CoV-2 is transmitted via the inhalation of infected droplets or through direct contact with contaminated surfaces. Aerosol-generating procedures can also lead to airborne transmission. Healthcare workers (HCWs) are at higher risks for infections than the general (...) Read More
Mert Ahmet Kuşkucu and others
As viruses spread through a population, they mutate and change, leading to the evolution of slightly different forms or variants. SARS-CoV-2 has been mutating ever since it was first detected in Wuhan, China, in December 2019. While most of the mutations will not have a significant effect on the spread of the virus, some mutations or (...) Read More
İrem Akdemir-Kalkan and others
SARS-CoV-2 has affected the whole world while the number of cases is increasing rapidly. Several reinfection cases have been reported with the rise in the number of infected people. It is important to study these reinfection cases as the knowledge gained can be used in critical decisions (...) Read More
Aral Sürmeli and others
Introduction The novel coronavirus (SARS-CoV-2) started in December 2019 in China, has infected over 4.2 million people worldwide, resulting in a death toll of 290 000 as of 13 May 2020 (1). It causes a multi-systemic infection named Coronavirus Disease 2019 (COVID-19). The symptoms reported are Read More
Oğuz Evlice and others
Introduction More than a year has passed since the beginning of the COVID-19 pandemic, and we are learning more about the long-term effects of the disease. While many patients recover completely, some continue to experience fatigue, dyspnea, cough, joint pain, and chest pain for weeks or even months (1).The UK National Institute for Health and […] Read More
Kenan Midilli
Coronaviruses are known to evolve slower than the other RNA viruses; however, SARS-CoV-2 underwent a major shift through D614G change in February 2020, even before the declaration of a pandemic by WHO and D614G variant became rapidly dominant throughout the world. The spike protein of this variant with D614G change have a higher affinity to […] Read More
Altan Gökgöz and others
Infectious Diseases and Clinical Microbiology (IDCM) physicians have pivotal role in responding to the coronavirus disease 2019 (COVID-19) pandemic. Their involvement ranges from managing cases and coordinating local responses to establishing timely and accurate diagnostic testing. Read More
İbrahim Etem Dural and Yasemin Nadir
The first case of COVID-19 was reported on 10 March 2020 in Turkey. Various treatment options have been used in all countries because of the lack of proven treatment. Among these options, hydroxychloroquine (HQN) and azithromycin (AZ) combination is expected to treat Read More
Uğur Kesimal
A 40-year-old female patient without any medical history presented to the emergency department with a 3-day history of neck pain and headache. She did not show any other symptoms. Her initial laboratory tests showed slightly increased C-reactive protein (6 mg/L; normal range 0-5 mg/L) and a normal white cell count. There were Read More
Gökhan Aygün and others
Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an Read More